Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,151 | 124 | 92.9% |
| Debt forgiveness | $164.92 | 3 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $329.79 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $242.58 | 14 | $0 (2022) |
| Amgen Inc. | $168.89 | 9 | $0 (2024) |
| Welch Allyn | $164.92 | 3 | $0 (2021) |
| Novo Nordisk Inc | $137.51 | 8 | $0 (2021) |
| AbbVie Inc. | $90.56 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $81.96 | 5 | $0 (2024) |
| Allergan, Inc. | $79.23 | 5 | $0 (2020) |
| PFIZER INC. | $76.69 | 6 | $0 (2024) |
| Lilly USA, LLC | $62.59 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $239.72 | 12 | Averitas Pharma Inc. ($41.83) |
| 2023 | $314.83 | 16 | GlaxoSmithKline, LLC. ($70.96) |
| 2022 | $218.07 | 13 | Novartis Pharmaceuticals Corporation ($62.30) |
| 2021 | $515.63 | 22 | Welch Allyn ($164.92) |
| 2020 | $211.15 | 13 | GlaxoSmithKline, LLC. ($62.20) |
| 2019 | $170.73 | 11 | Amgen Inc. ($37.25) |
| 2018 | $260.90 | 17 | Amgen Inc. ($47.06) |
| 2017 | $385.08 | 23 | Novartis Pharmaceuticals Corporation ($99.21) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: VACCINES | ||||||
| 09/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: NEUROLOGY | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: DIABETES | ||||||
| 08/15/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Inflammation | ||||||
| 07/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Cardio-renal | ||||||
| 04/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: VACCINES | ||||||
| 04/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Oncology | ||||||
| 02/16/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $41.83 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: UROLOGY | ||||||
| 02/07/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: VACCINES | ||||||
| 01/16/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Diabetes | ||||||
| 12/14/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: UROLOGY | ||||||
| 12/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.71 | General |
| 12/06/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: NEPHROLOGY | ||||||
| 10/30/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/26/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: VACCINES | ||||||
| 10/25/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Diabetes | ||||||
| 09/27/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: VACCINES | ||||||
| 08/17/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.65 | General |
| 08/04/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: RESPIRATORY | ||||||
| 05/03/2023 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Pharma Products | ||||||
| 04/24/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 7,972 | 14,889 | $652,590 | $324,193 |
| 2022 | 54 | 8,573 | 15,483 | $747,950 | $364,151 |
| 2021 | 65 | 10,811 | 20,080 | $952,470 | $476,465 |
| 2020 | 61 | 11,902 | 19,783 | $951,810 | $443,377 |
All Medicare Procedures & Services
228 procedure records from CMS Medicare Utilization — Page 8 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 814 | 1,519 | $22,785 | $11,722 | 51.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 112 | 112 | $28,560 | $11,043 | 38.7% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 41 | 46 | $16,330 | $8,870 | 54.3% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2020 | 160 | 181 | $14,480 | $7,394 | 51.1% |
| 82306 | Vitamin d-3 level | Office | 2020 | 214 | 232 | $12,750 | $6,793 | 53.3% |
| 90653 | Vaccine for influenza for injection into muscle | Office | 2020 | 111 | 111 | $9,990 | $6,608 | 66.1% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 85 | 115 | $11,475 | $5,880 | 51.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 106 | 110 | $12,100 | $5,455 | 45.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 856 | 1,757 | $34,970 | $5,238 | 15.0% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 31 | 31 | $9,765 | $4,869 | 49.9% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 140 | 253 | $8,855 | $4,662 | 52.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 27 | 27 | $8,370 | $4,422 | 52.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2020 | 244 | 265 | $7,915 | $3,957 | 50.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 34 | $7,480 | $3,824 | 51.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 60 | 64 | $7,040 | $3,719 | 52.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 40 | 57 | $6,555 | $3,339 | 50.9% |
| 81000 | Manual urinalysis test with examination using microscope | Office | 2020 | 684 | 817 | $8,110 | $3,253 | 40.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 69 | 320 | $11,200 | $3,195 | 28.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 187 | 188 | $7,520 | $3,111 | 41.4% |
| 80307 | Testing for presence of drug | Office | 2020 | 43 | 43 | $4,730 | $2,670 | 56.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2020 | 383 | 459 | $6,870 | $2,624 | 38.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 21 | 21 | $3,150 | $2,383 | 75.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2020 | 382 | 452 | $6,765 | $2,317 | 34.2% |
| 87426 | Coronavirus ag ia | Office | 2020 | 36 | 44 | $3,080 | $1,990 | 64.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 20 | 22 | $3,410 | $1,892 | 55.5% |
About Dr. Ma Aung, M.D
Dr. Ma Aung, M.D is a Internal Medicine healthcare provider based in Summerfield, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053358382.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ma Aung, M.D has received a total of $2,316 in payments from pharmaceutical and medical device companies, with $239.72 received in 2024. These payments were reported across 127 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($2,151).
As a Medicare-enrolled provider, Aung has provided services to 39,258 Medicare beneficiaries, totaling 70,235 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 228 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Summerfield, FL
- Active Since 06/02/2006
- Last Updated 01/11/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1053358382
Products in Payments
- ENTRESTO (Drug) $186.28
- None (Device) $164.92
- SHINGRIX (Biological) $149.62
- TRELEGY ELLIPTA (Drug) $93.49
- Ozempic (Drug) $91.52
- Enbrel (Biological) $90.65
- FARXIGA (Drug) $61.31
- COSENTYX (Biological) $56.30
- JYNARQUE (Drug) $53.10
- JARDIANCE (Drug) $52.33
- KRYSTEXXA (Drug) $49.05
- XIFAXAN (Drug) $48.94
- QULIPTA (Drug) $47.18
- GEMTESA (Drug) $47.10
- XARELTO (Drug) $42.02
- QUTENZA (Drug) $41.83
- EVENITY (Biological) $37.35
- Kerendia (Drug) $36.31
- VRAYLAR (Drug) $36.29
- TOUJEO (Drug) $33.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Summerfield
Dr. Marivic Villa, M.d, M.D
Internal Medicine — Payments: $6,986
Gloria Hernandez, Md, MD
Internal Medicine — Payments: $5,723
Luna Beck, M.d, M.D
Internal Medicine — Payments: $2,672
Mrs. Sara Gitte, Md, MD
Internal Medicine — Payments: $2,272
Dr. Page Smith, M.d, M.D
Internal Medicine — Payments: $2,256
Dr. Thomas Mathew, M.d, M.D
Internal Medicine — Payments: $2,075